Prothena Corp. (PRTA) Tops Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Prothena Corp. (PRTA) Tops Q3 EPS by 2c

Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update

November 7, 2017 4:05 PM EST

Net cash used in operating and investing activities was $18.3 million in the third quarter and $94.8 million for the first nine months of 2017; quarter-end cash and restricted cash position of $460.1 million, provides funding to advance diverse pipelinePresented new research at HFSA Annual Scientific Meeting on the important role of the cardiac biomarker NT-proBNP in AL amyloidosisR&D Day planned for Thursday, November 16th in New York, NY

DUBLIN, Ireland, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA), a late-stage clinical biotechnology... More